AzTrials
AzTrials

Frailty SyndromeFREXNCT07036224

The Effectiveness of Training Using Exergaming on Selected Physical and Psychological Parameters in a Population of Patients Over the Age of 65 Belonging to Specific Subgroups of the Frailty Syndrome

A study testing Exergaming Training using Kinect sensor device in people with Frailty Syndrome, run by Wroclaw Medical University at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the effects of a six-week exergaming-based training program on physical and psychological parameters in individuals aged 65 and older diagnosed with frailty or pre-frailty. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Frailty Syndrome
What is being tested?
Exergaming Training using Kinect sensor device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
111 participants
Where
1 sitePoland
Study dates
1 Mar 2022to 14 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • no medical contraindications to performing physical exercises in a standing position

Who cannot join

  • diagnosed moderate or severe stage of dementia
  • the presence of chronic diseases (e.g. chronic obstructive pulmonary disease, asthma, heart failure, arterial hypertension) that were uncontrolled or in an exacerbation phase

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Modelowa Praktyka Lekarza Rodzinnego Maria Bujnowska-Fedak

    Wroclaw, Lower Silesian Voivodeship, 51-141

Other trials in Poland

About this study

This study aims to evaluate the effects of a six-week exergaming-based training program on physical and psychological parameters in individuals aged 65 and older diagnosed with frailty or pre-frailty. Participants engage in supervised exergame sessions twice weekly using the Activlife rehabilitation platform, which combines physical exercises with cognitive tasks in a virtual environment. Outcomes are assessed using validated tools including the Fried Frailty Criteria, CES-D, IPAQ-SF, Katz ADL, Lawton IADL, VES-13, Tinetti Test, and Fullerton Fitness Test. Anthropometric and functional data are collected before and after the intervention.

Read the detailed description

Frailty is a clinical syndrome marked by reduced physiological reserve and increased vulnerability to adverse outcomes. Exergaming-interactive video game-based physical activity-offers a novel and potentially effective approach to counteracting physical and cognitive decline in frail older adults. While promising, existing evidence remains limited and methodologically heterogeneous.

This single-center trial investigates the effects of a six-week structured exergame training program on physical performance, functional independence, cognitive function, and mental well-being in a population of individuals aged 65+ with pre-frailty or frailty syndrome according to the Fried criteria.

Participants engage in at least 30-minute exergame-based sessions twice per week using the Activlife rehabilitation platform. The platform combines Kinect-based motion tracking with immersive therapeutic games that include physical (strength, balance, endurance) and cognitive (memory, visuospatial, logic) tasks. Sessions are supervised by a trained therapist, and game difficulty is adapted biweekly to participant capacity.

Assessments are conducted pre- and post-intervention and include: anthropometric data, frailty status (Fried criteria), depression symptoms (CES-D), physical activity (IPAQ-SF), basic and instrumental activities of daily living (Katz ADL, Lawton IADL), vulnerability (VES-13), mobility and balance (Tinetti Test), and physical fitness (Fullerton Fitness Test).

Ethical approval was obtained from the Bioethics Committee of Wroclaw Medical University (approval no. 172/2019). All participants provided written informed consent. The study adheres to the Declaration of Helsinki.

Being tested
Exergaming Training using Kinect sensor device
Keywords
frailty, older people, exergaming
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exergaming Training using Kinect sensor deviceDevice

    A 6-week standardized training program was carried out with the use of the game rehabilitation platform with Kinect sensor device. The subjects exercised under the supervision of an instructor for at least 30 minutes twice a week.

Study groups in NCT07036224
Study groupRoleWhat they receive
Exergaming TrainingOtherA 6-week standardized training program was carried out with the use of the game rehabilitation platform with Kinect sensor device. The subjects exercised under the supervision of an instructor for at least 30 minutes twice a week.
Receives: Device: Exergaming Training using Kinect sensor device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Frailty Category Based on Fried Frailty Phenotype Criteria

    Frailty status will be assessed using the Fried Frailty Phenotype, which includes five criteria: unintentional weight loss, weakness (handgrip strength), slowness (gait speed), exhaustion (CES-D), and low physical activity (IPAQ-SF). Each criterion met scores 1 point (range: 0-5). Participants are classified as: robust (0 points), pre-frail (1-2 points), or frail (≥3 points). The outcome is the change in frailty category from baseline to study completion. Improvement is defined as transition to a lower-risk category (e.g., frail to pre-frail), while worsening is a shift to a higher-risk category. A decrease in frailty category indicates improvement.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

Secondary outcomes (10)
  1. Frailty Score Assessed by Fried Frailty Phenotype Scale

    Frailty will be assessed using the Fried frailty phenotype scale, which includes five criteria: unintentional weight loss, weakness (handgrip strength), slowness (gait speed), exhaustion (CES-D items), and low physical activity (IPAQ-SF). The score ranges from 0 to 5; higher scores indicate a worse frailty status.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  2. Depression Symptoms Assessed by the Geriatric Depression Scale (GDS-15)

    The Geriatric Depression Scale (GDS-15) includes 15 yes/no questions. Scores range from 0 to 15; higher scores indicate more severe depressive symptoms. A score ≥6 indicates increased risk of depression.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  3. Cognitive Function Assessed by the Montreal Cognitive Assessment (MoCA)

    The MoCA evaluates cognitive domains including memory, attention, and visuospatial abilities. Total score ranges from 0 to 30; higher scores indicate better cognitive function. A score below 26 suggests mild cognitive impairment.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  4. Functional Status Assessed by the Katz Index of Independence in Activities of Daily Living (ADL)

    The ADL index assesses six basic self-care activities. Scores range from 0 to 6; higher scores indicate greater independence.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  5. Instrumental Activities of Daily Living Assessed by the Lawton-Brody Scale (IADL)

    The IADL scale evaluates 8 instrumental daily tasks. Scores range from 8 to 24; higher scores indicate greater functional independence.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  6. Physical Fitness Assessed by the Fullerton Fitness Test (Senior Fitness Test)

    The Fullerton Fitness Test evaluates physical fitness in older adults across six domains.

    Chair Stand Test: number of stands in 30 seconds (lower body strength). Arm Curl Test: arm curls in 30 seconds with 2 kg (women) or 3.6 kg (men) dumbbell (upper body strength).

    Chair Sit and Reach: distance (cm) between fingertips and toes while reaching forward from a seated position (lower body flexibility).

    Back Scratch Test: distance (cm) between fingertips reaching behind the back (upper body flexibility).

    8-Foot Up and Go: time (sec) to stand, walk 2.44 m, turn, and sit (balance/agility).

    6-Minute Walk or 2-Minute Step: total distance or number of steps (aerobic endurance).

    Each test is scored separately; higher values generally indicate better fitness, except for the Up and Go test, where lower times reflect better performance.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  7. Balance and Gait Assessed by the Tinetti Performance-Oriented Mobility Assessment (POMA)

    The POMA evaluates balance and gait. Scores range from 0 to 28; scores <25 indicate risk of falling, and <19 indicate high fall risk.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  8. Health-Related Quality of Life Assessed by the Short Form-36 (SF-36) Health Survey

    The SF-36 measures quality of life across 8 domains. Scores range from 0 to 100 for each domain; higher scores indicate better perceived health.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  9. Functional Vulnerability Assessed by the Vulnerable Elders Survey-13 (VES-13)

    The VES-13 evaluates self-reported physical function and age-related risk. Scores range from 0 to 10; a score ≥3 indicates increased risk of functional decline.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

  10. Depression Symptoms Assessed by the Geriatric Depression Scale (GDS-15)

    The Geriatric Depression Scale (GDS-15) is a screening tool consisting of 15 yes/no questions. Scores range from 0 to 15; higher scores indicate more severe depressive symptoms. A score of 6 or higher suggests an increased risk of depression in older adults.

    Measured: Baseline and through completion of exergaming training program (an average of 6 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2025
  2. Study start1 Mar 2022
  3. Primary completion30 Nov 2024
  4. Study completion14 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
111 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07036224
Sponsor's protocol ID
Frailty Exergaming KB172/2019
Acronym
FREX
Status last verified
Jun 2025
First submitted
5 Jun 2025
Last updated
29 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Bujnowska-Fedak MM, Sobieski M, Fedak A, Waligora J. The ActivLife exergame rehabilitation program improves functional abilities in pre-frail and frail older adults: a clinical trial. Sci Rep. 2026 Mar 9;16(1):12637. doi: 10.1038/s41598-026-38989-4.

    PubMed 41796126

Questions about this trial

What is this clinical trial studying?

A study testing Exergaming Training using Kinect sensor device in people with Frailty Syndrome, run by Wroclaw Medical University at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Frailty Category Based on Fried Frailty Phenotype Criteria (time frame: Baseline and through completion of exergaming training program (an average of 6 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07036224, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in